ASCO 2016: Natural Killer Cell-Based Therapies in Blood Cancers
As part of our coverage of the annual ASCO conference, we spoke with Dr. Veronika Bachanova on the role of NK cell therapy in hematologic malignancies.
AACR: Merkel Cell Carcinoma Responsive to Anti-PD-1 Immunotherapy
Patients with metastatic Merkel cell carcinoma treated with pembrolizumab (Keytruda, Merck) as a first-line therapy had durable responses in a phase II clinical trial.
Novel Two-Step Immunotherapy Shows Promise in Early-Stage Ovarian Cancer Study
A two-step immunotherapy approach consisting of adoptive T-cell therapy and a dendritic cell vaccine has shown activity in a phase I advanced ovarian cancer clinical trial.